Tilray Brands (NASDAQ:TLRY) Stock Falls 1.6% – Time to Sell?

Tilray Brands, Inc. (NASDAQ:TLRY)’s stock price fell 1.6% during mid-day trading on Wednesday. The company traded as low as $3.70 and last traded at $3.72. Approximately 3,254,090 shares were traded during trading, a decline of 23% from the average session volume of 4,203,233 shares. The stock had previously closed at $3.78.

Tilray Brands News Summary

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray reported record first-quarter revenue of approximately $257.1 million, up 23% year over year, while gross profit increased 35% to $77.5 million and gross margin expanded to about 30%. Tilray revenue rises as beverage business drives record quarterly sales
• Positive Sentiment: The beverage segment was a major growth driver, generating roughly $101 million in revenue, with sales reportedly up 82%. BrewDog also reached profitability, supporting management’s strategy of diversifying beyond cannabis. Tilray Q1 2027 earnings call transcript
• Positive Sentiment: International operations continued to accelerate, with EMEA revenue rising 71%, led by medical cannabis, beverages and pharmaceutical distribution. Tilray reduced debt by $42 million during the fiscal year and reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million. Tilray fiscal Q1 2027 results
• Neutral Sentiment: The results suggest Tilray is building growth without relying entirely on potential U.S. cannabis reform, as beverage and European medical-cannabis expansion helped offset softness in Canada. Options commentary is nevertheless optimistic, pointing to expectations for a near-term rebound. Tilray finds a path to growth without waiting on U.S. cannabis reform
• Negative Sentiment: Investors focused on the bottom line and the revenue miss: reported revenue of $257.1 million trailed the roughly $266.3 million consensus, while Tilray posted a loss and swung to an adjusted loss. Tilray swings to adjusted loss
• Negative Sentiment: Cannabis sales declined, raising concerns that the company’s core business is weakening despite beverage growth. The stock is trading near its 52-week low and below both its 50-day and 200-day moving averages, reinforcing bearish technical momentum. Tilray record revenue masks shrinking cannabis sales

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on TLRY. TD dropped their price target on shares of Tilray Brands from $4.70 to $4.50 and set a “buy” rating on the stock in a research note on Monday. ATB Cormark Capital Markets dropped their target price on shares of Tilray Brands from $8.00 to $6.00 and set a “hold” rating on the stock in a research note on Monday, September 21st. Canaccord Genuity Group cut their price target on shares of Tilray Brands from $4.50 to $4.00 and set a “hold” rating on the stock in a report on Friday. Zacks Research lowered shares of Tilray Brands from a “hold” rating to a “strong sell” rating in a report on Tuesday, September 29th. Finally, Wall Street Zen cut Tilray Brands from a “hold” rating to a “sell” rating in a research report on Saturday, August 1st. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $5.90.

Tilray Brands Stock Down 2.1%

The company’s 50 day moving average price is $4.31 and its two-hundred day moving average price is $5.03. The company has a current ratio of 2.21, a quick ratio of 1.37 and a debt-to-equity ratio of 0.22. The firm has a market cap of $478.76 million, a PE ratio of -3.25 and a beta of 1.91.

Tilray Brands (NASDAQ:TLRY) last released its earnings results on Tuesday, July 28th. The company reported ($0.43) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.42). The firm had revenue of $281.71 million for the quarter, compared to the consensus estimate of $246.30 million. Tilray Brands had a negative return on equity of 7.76% and a negative net margin of 13.11%. On average, equities research analysts expect that Tilray Brands, Inc. will post -0.48 EPS for the current fiscal year.

Insider Activity at Tilray Brands

In other Tilray Brands news, CFO Carl Merton acquired 10,000 shares of the stock in a transaction on Tuesday, August 4th. The stock was acquired at an average price of $4.62 per share, for a total transaction of $46,200.00. Following the completion of the transaction, the chief financial officer directly owned 139,753 shares of the company’s stock, valued at $645,658.86. This trade represents a 7.71% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last ninety days, insiders purchased 15,000 shares of company stock worth $69,225. 1.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Tilray Brands

Hedge funds and other institutional investors have recently made changes to their positions in the company. Integrated Wealth Concepts LLC bought a new stake in shares of Tilray Brands during the second quarter worth $27,000. Hilton Head Capital Partners LLC purchased a new position in Tilray Brands in the 4th quarter worth about $38,000. Deutsche Bank AG bought a new stake in Tilray Brands during the 2nd quarter valued at about $44,000. Corient Private Wealth LP bought a new stake in Tilray Brands during the 2nd quarter valued at about $53,000. Finally, Essential Partners LLC boosted its position in Tilray Brands by 110,137.5% in the 1st quarter. Essential Partners LLC now owns 8,819 shares of the company’s stock valued at $57,000 after buying an additional 8,811 shares during the period. Hedge funds and other institutional investors own 9.35% of the company’s stock.

About Tilray Brands

Tilray Brands, Inc is a global consumer packaged goods company focused on cannabis, beverage alcohol, wellness and consumer products. The company develops, produces, distributes and markets a range of cannabis products, including dried flower, pre-rolls, vapes, edibles and medical cannabis products, subject to applicable regulations in the markets it serves.

Tilray also operates beverage alcohol businesses, including craft beer, spirits and other alcoholic beverages. Its portfolio has included brands such as SweetWater Brewing Company, Montauk Brewing Company and Breckenridge Distillery.